The COVID19 epidemic has spurred a global public health crisis. While many of the cases requiring hospitalization and intensive medical care center on cardiorespiratory treatment, a growing number of cases present neurological symptoms. Viral entry into the brain now appears a strong possibility with deleterious consequences and an urgent need for addressing.

A Molecular Pharmacology perspective titled "Does COVID19 Infect the Brain? If So, Smokers Might Be at a Higher Risk" by Nadine Kabbani and James L Olds of George Mason University is now online in manuscript form and freely accessible to all.